Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,712,859
in 10 filings, $1.0M under 10b5-1 plans

Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 50 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-08-01 Ring Christine General Counsel Sale −712 $15.67 $11K 4,615
2022-08-01 Wolff Stefani EVP and COO Sale −356 $15.67 $6K 1,238
2022-08-01 van Houte Hans Chief Financial Officer Sale −752 $15.67 $12K 72,656
2022-08-01 Hansen Gwenn Chief Scientific Officer Sale −1,186 $15.67 $19K 19,172
2022-07-30 Ring Christine General Counsel Option exercise +1,924 5,327
2022-07-30 Ring Christine General Counsel Option exercise · Restricted Stock Units −1,924 26,937
2022-07-30 Wolff Stefani EVP and COO Option exercise +962 1,594
2022-07-30 Wolff Stefani EVP and COO Option exercise · Restricted Stock Units −962 13,468
2022-07-30 van Houte Hans Chief Financial Officer Option exercise +2,886 73,408
2022-07-30 van Houte Hans Chief Financial Officer Option exercise · Restricted Stock Units −2,886 40,405
2022-07-30 Hansen Gwenn Chief Scientific Officer Option exercise +3,207 20,358
2022-07-30 Hansen Gwenn Chief Scientific Officer Option exercise · Restricted Stock Units −3,207 44,895
2022-05-31 van Houte Hans Chief Financial Officer Option exercise +68,333 $0.84 $57K 70,522
2022-05-31 van Houte Hans Chief Financial Officer Option exercise · Employee Stock Option (right to buy) −68,333 0
2022-05-05 Silva Paul M Director Grant or award · Director Stock Option (right to buy) +17,500 17,500
2022-05-05 SIEGALL CLAY B Director Grant or award · Director Stock Option (right to buy) +17,500 17,500
2022-05-05 Reinsdorf Judith A Director Grant or award · Director Stock Option (right to buy) +17,500 17,500
2022-05-05 Lacey David L. Director Grant or award · Director Stock Option (right to buy) +17,500 17,500
2022-05-05 Kunkel Lori Anne Director Grant or award · Director Stock Option (right to buy) +17,500 17,500
2022-05-05 GREGORY JULIA P Director Grant or award · Director Stock Option (right to buy) +17,500 17,500

Page 28 of 32 · 632 trades